ANS sets new rules for supply of medication for home use

Resolution of the National Health Agency (ANS), published on Wednesday (31) in Diário Oficial da União defines rules for the provision of medication to use home health plan beneficiaries with chronic illnesses.

Through a statement, the NSA said the measures aim to improve the treatment of diseases most prevalent in the Brazilian population: diabetes mellitus, bronchial asthma, chronic obstructive pulmonary disease, hypertension, coronary artery disease and congestive heart failure.

In an interview with Brazil Agency, the General Manager of Regulatory Assistance ANS, Martha Oliveira explained that the resolution applies only to beneficiaries of individual health plans. In the case of collective plans, she said, there will be a joint negotiation to determine which medications are most appropriate for the group.

The profile of a collective level can be very different [of a plan] for the general population. You can sell the product for an industry that has only young women, then, many of these diseases may not be the priority, he said.

According to ANS, offering this type of coverage is optional, since Article 10 of the 9656 Act allows the exclusion of the provision of home medication by health plans. Moreover, as it is an ancillary agreement may have cost to beneficiaries. The agency said it would offer incentives to operators who offer this type of treatment.

• Tweet